2.44 0.13 (5.63%) | 03-28 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 3.64 | 1-year : | 4.25 |
Resists | First : | 3.11 | Second : | 3.64 |
Pivot price | 2.19 | |||
Supports | First : | 2.13 | Second : | 1.52 |
MAs | MA(5) : | 2.3 | MA(20) : | 2.32 |
MA(100) : | 3.03 | MA(250) : | 0 | |
MACD | MACD : | -0.2 | Signal : | -0.3 |
%K %D | K(14,3) : | 64.3 | D(3) : | 57.7 |
RSI | RSI(14): 49.8 | |||
52-week | High : | 48.99 | Low : | 1.52 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ MGRM ] has closed below upper band by 21.7%. Bollinger Bands are 2.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 2.57 - 2.58 | 2.58 - 2.59 |
Low: | 2.36 - 2.37 | 2.37 - 2.38 |
Close: | 2.42 - 2.44 | 2.44 - 2.46 |
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Thu, 28 Mar 2024
Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Short Interest Update - MarketBeat
Tue, 26 Mar 2024
Monogram Orthopaedics (NASDAQ:MGRM) and Treace Medical Concepts (NASDAQ:TMCI) Head-To-Head Survey - Defense World
Tue, 26 Mar 2024
Equities Analysts Set Expectations for Monogram Orthopaedics, Inc.'s Q1 2024 Earnings (NASDAQ:MGRM) - MarketBeat
Mon, 25 Mar 2024
Monogram Orthopaedics, Inc. Forecasted to Post Q1 2024 Earnings of ($0.12) Per Share (NASDAQ:MGRM) - Defense World
Fri, 22 Mar 2024
Is Monogram Orthopaedics (NASDAQ:MGRM) In A Good Position To Invest In Growth? - Simply Wall St
Thu, 21 Mar 2024
Monogram Orthopaedics, Inc. (MGRM) Q4 2023 Earnings Call Transcript - Seeking Alpha
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Medical - Devices
|
|
Shares Out | 0 (M) |
Shares Float | 32 (M) |
Held by Insiders | 2.225e+007 (%) |
Held by Institutions | 38.7 (%) |
Shares Short | 4 (K) |
Shares Short P.Month | 0 (K) |
EPS | -1.686e+007 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 0 |
Profit Margin | 0 % |
Operating Margin | -1 % |
Return on Assets (ttm) | 62.1 % |
Return on Equity (ttm) | -71.4 % |
Qtrly Rev. Growth | 365000 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 0 |
EBITDA (p.s.) | -0.52 |
Qtrly Earnings Growth | -0.7 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | -14 (M) |
PE Ratio | -0.01 |
PEG Ratio | 0 |
Price to Book value | 0 |
Price to Sales | 0 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 5740 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |